InvestorsHub Logo
Followers 188
Posts 28577
Boards Moderated 1
Alias Born 08/29/2012

Re: JamesF1 post# 380662

Saturday, 06/03/2023 10:46:38 AM

Saturday, June 03, 2023 10:46:38 AM

Post# of 399296
Purdue Patents for Extended-Release OxyContin Nixed in Intas Win

Judge agrees with Intas’ Accord, cancels five Purdue patents
‘Existing monopoly’ fueled abuse-deterrent version’s success
A federal judge voided five patents Purdue Pharma LP alleges are infringed by generic versions of extended-release OxyContin proposed by Intas Pharmaceuticals Ltd.’s Accord unit, finding they cover obvious inventions and shouldn’t have been issued.

https://news.bloomberglaw.com/ip-law/purdue-patents-for-extended-release-oxycontin-nixed-in-intas-win
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News